Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

18-NEU-986-Cancer stem cells-650×450

Kinase Inhibitor Ibrutinib Shows Preclinical Promise in Glioblastoma

Established lymphoma/leukemia therapy also targets glioma stem cells

18-NEU-781-Recinos-Epigenetic-Targeting-650×450
May 7, 2018/Cancer

Epigenetic Targeting: A New Avenue in the Fight Against Pediatric High-Grade Glioma

An array of investigations underway at Cleveland Clinic

18-NEU-733-Pediatric-MS-650×450

Pediatric-Onset MS: Study Confirms Some Features, Flags Others as Research Priorities

Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs

18-NEU-823-Hantus-EEG-650×450
April 26, 2018/Neurosciences/Research

How Long to Monitor with cEEG? New Data Help Shape Choices

Large study gives guidance based on mental status, seizure etiology

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-817-Foldvary-Sleep-Neuro-650×450
April 22, 2018/Neurosciences/Research

High Prevalence of Insomnia and Sleep Apnea Found Among Patients with Diverse Neuro Diseases

Should sleep history be incorporated into routine neurological care?

18-NEU-736-Friedman-Pediatric-Stroke-650×450
April 20, 2018/Neurosciences/Research

VIPS II Study Homes In on Pediatric Arterial Ischemic Stroke

A key focus is characterizing arteriopathy, a prime predictor of recurrence

18-NEU-810-Stroke-Rehab-Katzan-650×450 (003)
April 13, 2018/Geriatrics

Post-Stroke Health Impacts Merit New Emphases in Stroke Survivor Care

Executive function, social roles and physical function loom large in new study

18-NEU-678-Progressive MS-650×450
March 23, 2018/Neurosciences/Research

Disability Progression Slowed for First Time in Large Trial of Secondary Progressive MS

Phase 3 EXPAND trial suggests potential utility of siponimod

18-NEU-505-Fernandez-Parkinson-Spark
March 12, 2018/Neurosciences/Research

Disease-Modifying Parkinson Therapy Is Put to the Test in Phase 2 Trial

Novel monoclonal antibody takes aim at alpha-synuclein clusters

18-NEU-618-Vogelbaum-Brain-Tumor-650×450
March 1, 2018/Cancer

In Brain Tumor Therapeutics, Options for Bypassing the Blood-Brain Barrier Are Burgeoning

Cleveland Clinic offers an abundance of direct delivery trials

BackPage 13 of 17Next

Advertisement

Ad